clinical trial · NCT07071714
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.·phase2·recruiting·n = 200
Colorectal CancerSHR-8068 InjectionAdebrelimab InjectionBevacizumab Injection
brief summary
The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-8068 injection in combination with anti-tumor therapies in subjects with colorectal cancer.
started
Jul 22, 2025
primary completion
Oct 1, 2031
completion
Oct 1, 2031
last updated
Mar 18, 2026
official title
An Open, Multicenter Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol